Sex (male:female) | 13:7 |
Age (years) (mean ± SD) | 63.35 ± 11.49 |
Body mass index (kg/m2) (median, range) | 25 (22.9–29.5) |
ASA grade (n, %) | |
I–II | 12 (60%) |
III–IV | 8 (40%) |
Platelets (mean ± SD) | 208,600 ± 73,650 |
Prothrombin activity percentage (mean ± SD) | 94.47 ± 10.44 |
HVPG (mmHg) (mean ± SD) | 3.80 ± 1.67 |
Elastography (kPa) (mean ± SD) | 5.41 ± 1.67 |
No. of metastases (mean ± SD) | 2.26 ± 1.94 |
Occurrence of metastases (n, %) | |
Synchronous | 9 (45%) |
Metachronous | 11 (55%) |
Steatosis (%) | 45 |
Inflammation (%) | 45 |
Fibrosis (%) | 65 |